نتائج البحث - Yoo‐Na Kim

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells

    Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells حسب Yoo Na Kim, Ketki Patil, S. Balakrishna Pai

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer

    Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer حسب Yoo‐Na Kim, Yun Soo Chung, Eunhyang Park, Seung‐Tae Lee, Jung‐Yun Lee

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Maternal age and risk of early neonatal mortality: a national cohort study

    Maternal age and risk of early neonatal mortality: a national cohort study حسب Yoo‐Na Kim, Dong‐Woo Choi, Dong Seop Kim, Eun‐Cheol Park, Ja‐Young Kwon

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With <i>BRCA</i>-Mutated Ovarian Cancer

    Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With <i>BRCA</i>-Mutated Ovarian Cancer حسب Yoo‐Na Kim, Yeeun Shim, Jieun Seo, Zisun Choi, Yong Jae Lee, Saeam Shin, Sang Wun Kim, Sunghoon Kim, Jong Rak Choi, Jung‐Yun Lee, Seung‐Tae Lee

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4

    Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase... حسب Yoo‐Na Kim, Boram Park, Jae‐Weon Kim, Byoung Gie Kim, Sang Wun Kim, Hee Seung Kim, Chel Hun Choi, Myong Cheol Lim, Natalie Ngoi, David S.P. Tan, Jung‐Yun Lee

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

    The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples حسب James E. Barrett, Chiara Herzog, Allison Jones, Olivia C. Leavy, Iona Evans, Susanne Knapp, Daniel Reisel, Tatiana Nazarenko, Yoo‐Na Kim, D. Franchi, Andy Ryan, Joanna Franks, Line Bjørge, Michal Zikán, David Cibula, Nadia Harbeck, Nicoletta Colombo, Frank Dudbridge, J. Louise Jones, Karin Sundström, Joakim Dillner, Angelique Flöter Rådestad, Kristina Gemzell‐Danielsson, Nora Pashayan, Martin Widschwendter

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: